Literature DB >> 26036575

Humanization of a phosphothreonine peptide-specific chicken antibody by combinatorial library optimization of the phosphoepitope-binding motif.

Du-San Baek1, Yong-Sung Kim2.   

Abstract

Detection of protein phosphorylation at a specific residue has been achieved by using antibodies, which have usually been raised by animal immunization. However, there have been no reports of the humanization of phosphospecific non-human antibodies. Here, we report the humanization of a chicken pT231 antibody specific to a tau protein-derived peptide carrying the phosphorylated threonine at residue 231 (pT231 peptide) as a model for better understanding the phosphoepitope recognition mechanism. In the chicken antibody, the phosphate group of the pT231-peptide antigen is exclusively recognized by complementarity determining region 2 of the heavy chain variable domain (VH-CDR2). Simple grafting of six CDRs of the chicken antibody into a homologous human framework (FR) template resulted in the complete loss of pT231-peptide binding. Using a yeast surface-displayed combinatorial library with permutations of 11 FR residues potentially affecting CDR loop conformations, we identified 5 critical FR residues. The back mutation of these residues to the corresponding chicken residues completely recovered the pT231-peptide binding affinity and specificity of the humanized antibody. Importantly, the back mutation of the FR 76 residue of VH (H76) (Asn to Ser) was critical in preserving the pT231-binding motif conformation via allosteric regulation of ArgH71, which closely interacts with ThrH52 and SerH52a residues on VH-CDR2 to induce the unique phosphate-binding bowl-like conformation. Our humanization approach of CDR grafting plus permutations of FR residues by combinatorial library screening can be applied to other animal antibodies containing unique binding motifs on CDRs specific to posttranslationally modified epitopes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibody engineering; Chicken antibody; Humanization; Phosphospecific antibody; Phosphothreonine-binding motif

Mesh:

Substances:

Year:  2015        PMID: 26036575     DOI: 10.1016/j.bbrc.2015.05.086

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies.

Authors:  Sue Townsend; Brian J Fennell; James R Apgar; Matthew Lambert; Barry McDonnell; Joanne Grant; Jason Wade; Edward Franklin; Niall Foy; Deirdre Ní Shúilleabháin; Conor Fields; Alfredo Darmanin-Sheehan; Amy King; Janet E Paulsen; Timothy P Hickling; Lioudmila Tchistiakova; Orla Cunningham; William J J Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

2.  Site-directed mutations of anti-amantadine scFv antibody by molecular dynamics simulation: prediction and validation.

Authors:  Sanlei Xie; Jianyi Wang; Xuezhi Yu; Tao Peng; Kai Yao; Sihan Wang; Demei Liang; Yuebin Ke; Zhanhui Wang; Haiyang Jiang
Journal:  J Mol Model       Date:  2020-02-04       Impact factor: 1.810

3.  Humanization of Chicken-Derived Antibodies by Yeast Surface Display.

Authors:  Jan P Bogen; Adrian Elter; Julius Grzeschik; Björn Hock; Harald Kolmar
Journal:  Methods Mol Biol       Date:  2022

4.  Yeast Mating as a Tool for Highly Effective Discovery and Engineering of Antibodies via Display Methodologies.

Authors:  Du-San Baek; Seong-Wook Park; Cynthia Adams; Dimiter S Dimitrov; Yong-Sung Kim
Journal:  Methods Mol Biol       Date:  2022

5.  The Combining Sites of Anti-lipid A Antibodies Reveal a Widely Utilized Motif Specific for Negatively Charged Groups.

Authors:  Omid Haji-Ghassemi; Sven Müller-Loennies; Teresa Rodriguez; Lore Brade; Hans-Dieter Grimmecke; Helmut Brade; Stephen V Evans
Journal:  J Biol Chem       Date:  2016-03-01       Impact factor: 5.157

Review 6.  Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins.

Authors:  Ji-Hee Ha; Jung-Eun Kim; Yong-Sung Kim
Journal:  Front Immunol       Date:  2016-10-06       Impact factor: 7.561

7.  Assessing kinetic and epitopic diversity across orthogonal monoclonal antibody generation platforms.

Authors:  Yasmina Noubia Abdiche; Rian Harriman; Xiaodi Deng; Yik Andy Yeung; Adam Miles; Winse Morishige; Leila Boustany; Lei Zhu; Shelley Mettler Izquierdo; William Harriman
Journal:  MAbs       Date:  2015-12-14       Impact factor: 5.857

8.  Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration.

Authors:  Seung-Min Shin; Dong-Ki Choi; Keunok Jung; Jeomil Bae; Ji-Sun Kim; Seong-Wook Park; Ki-Hoon Song; Yong-Sung Kim
Journal:  Nat Commun       Date:  2017-05-10       Impact factor: 14.919

9.  Generation of a highly diverse panel of antagonistic chicken monoclonal antibodies against the GIP receptor.

Authors:  Jennifer D Könitzer; Shreya Pramanick; Qi Pan; Robert Augustin; Sebastian Bandholtz; William Harriman; Shelley Izquierdo
Journal:  MAbs       Date:  2017-01-05       Impact factor: 5.857

10.  Engineering of Immunoglobulin Fc Heterodimers Using Yeast Surface-Displayed Combinatorial Fc Library Screening.

Authors:  Hye-Ji Choi; Ye-Jin Kim; Dong-Ki Choi; Yong-Sung Kim
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.